After six weeks the patients in the trial were sick of the shart stains in their pants. This will be brought up in the review.
Let's be crystal clear. If the FDA follows through with reneging of the Anchor SPA and issues either a CRL or delays full approval December 20 the I have full intentions to request through a Citizen Petition the FDA follows USC 21 chapter 9. I will request all NDA of non orphan status be put on hold until the full investigation into Brilinta's PLATO trial is complete. Do you hear me AZN? If I discover any big Pharma has involvement colluding with Mary Parks or Eric Coleman to use Regulatory Abuse to delay NCE, Patent extension, Anchor, and the destruction of Amarin shareholder value, you WILL suffer the full penalty of USC 21 chapter 9. Not only will you be fined you will be prohibited from marketing for 10 years in the USA.
There's a reason why America was formed in 1796, British Pharma, there's a small Dublin Pharma that has your name and we're ready for a serious war.
News 
Market Data 
Discover 
